Powered by OpenAIRE graph
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ American Journal of ...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
American Journal of Hematology
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
American Journal of Hematology
Article . 2014 . Peer-reviewed
License: Wiley Online Library User Agreement
Data sources: Crossref
American Journal of Hematology
Article . 2014
Data sources: Europe PubMed Central
American Journal of Hematology
Article
Data sources: Microsoft Academic Graph
 View all 2 versions

Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10)

descriptionPublicationkeyboard_double_arrow_right Article 16 May 2014 English Publisher:WileyJournal:American Journal of Hematology, volume 89, pages 862-862 (issn: 0361-8609, eissn: 1096-8652, Copyright policy )
Authors: Anjali S. Advani; Shashirekha Shetty; Edy Hasrouni; Valeria Visconte; Chris Gerace; Ali Tabarroki; Mikkael A. Sekeres; +9 Authors

doi: 10.1002/ajh.23755

pmid: 24796269

Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10)

Related Organizations
Keywords

Male, Myeloproliferative Disorders, Serine-Arginine Splicing Factors, Nuclear Proteins, Middle Aged, Isochromosomes, Ribonucleoproteins, Hematologic Neoplasms, Mutation, Humans, Female, Carrier Proteins, Aged, Chromosomes, Human, Pair 17, Granulocytes

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 11
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Top 10%
Powered by OpenAIRE graph
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
11
Top 10%
Average
Top 10%
bronze